EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Aspirin vs heparin: a comparative review of antiplatelet and anticoagulant therapy

Swamy K, Indhu Harini S, Deepthi P, Siva Parvathi A, BhanuSri Sai T

Learnovate-International · 2025

DOI: 10.70604/learnint.v2i3.104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Learnovate-International, 2025. Verfasst von Swamy K und 4 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspirin and Heparin are two widely used agents in the prevention and treatment of thromboembolic disorders, yet they differ fundamentally in their mechanisms of action, clinical applications and pharmacological profiles. Aspirin, an antiplatelet agent, primarily inhibits cyclooxygenase-1[COX1] thereby Suppressing thromboxane Az Synthesis and preventing platelet aggregation. It is mainly indicated in arterial thrombosis, such as myocardial infarction and stroke prevention. In contrast, heparin is an anticoagulant that enhances the activity of antithrombin 111, inhibiting thrombin and factor Xa, thus interfering with the coagulation Cascade. It is Commonly used in venous thromboembolism, deep vein thrombosis, pulmonary embolism, and during surgeries or dialysis. This review compares their pharmacodynamics, indications, side effect profiles and clinical outcomes, highlighting the Complementary yet distinct roles of antiplatelet and anticoagulant therapy. The selection between aspirin and heparin is guided by the type of thrombosis, patient risk factors, and therapeutic goals, underlining the importance of individualized treatment strategies in cardiovascular and hematological care.

Zitieren

APA

K, S., S, I. H., P, D., A, S. P., & T, B. S. (2025). Aspirin vs heparin: a comparative review of antiplatelet and anticoagulant therapy. Learnovate-International. https://doi.org/10.70604/learnint.v2i3.104

Vancouver

K S, S IH, P D, A SP, T BS. Aspirin vs heparin: a comparative review of antiplatelet and anticoagulant therapy. Learnovate-International. 2025. doi:10.70604/learnint.v2i3.104

BibTeX
@article{K2025,
  author = {K, Swamy and S, Indhu Harini and P, Deepthi and A, Siva Parvathi and T, BhanuSri Sai},
  title = {Aspirin vs heparin: a comparative review of antiplatelet and anticoagulant therapy},
  journal = {Learnovate-International},
  year = {2025},
  doi = {10.70604/learnint.v2i3.104}
}
Kostenlos starten →